Sulphasalazine versus penicillamine in the treatment of rheumatoid arthritis

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Rheumatology International

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF00270980PMID 2567049
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Salazopyrin in rheumatoid arthritis

  1994cited by this paper
• Sulphasalazine and ankylosing spondylitis: an open pilot study.

  1989cited by this paper
• Effect of sulphasalazine on the radiological progression of rheumatoid arthritis.

  1987cited by this paper
• Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods.

  1987cited by this paper
• Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.

  1986cited by this paper
• A double‐blind, placebo‐controlled trial

  1986cited by this paper
• Sulphasalazine for rheumatoid arthritis: relationship between dose, acetylator phenotype and response to treatment.

  1986cited by this paper
• Sulfasalazine in rheumatoid arthritis. A double-blind, placebo-controlled trial.

  1986cited by this paper
• Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis.

  1985cited by this paper
• Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.

  1985cited by this paper
• Sulfasalazine in severe rheumatoid arthritis: a study to assess potential correlates of efficacy and toxicity.

  1985cited by this paper
• Sulfasalazine and ankylosing spondylitis.

  1984cited by this paper
• Sulphasalazine in rheumatoid arthritis.

  1984cited by this paper
• Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone.

  1984cited by this paper
• Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.

  1983cited by this paper
• Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.

  1983cited by this paper
• A biochemical assessment of sulphasalazine in rheumatoid arthritis.

  1982cited by this paper
• Sulphasalazine in rheumatoid arthritis.

  1980cited by this paper
• Measurement of patient outcome in arthritis.

  1980cited by this paper
• Salazopyrin in rheumatoid arthritis

  1978cited by this paper
• Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report.

  1974cited by this paper
• Controlled trial of D(-)penicillamine in severe rheumatoid arthritis.

  1973cited by this paper
• Simplified Method for Determining Acetylator Phenotype

  1972cited by this paper
• Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

  1968cited by this paper

• Monotreatment With Conventional Antirheumatic Drugs or Glucocorticoids in Rheumatoid Arthritis

  2023cites this paper
• Strategies toward rheumatoid arthritis therapy; the old and the new

  2018cites this paper
• RADIOGRAFÍA SIMPLE Y ARTRITIS REUMATOIDE. LECTURA SISTEMÁTICA DE LA PROGRESIÓN RADIOLÓGICA

  2016cites this paper
• Sulfasalazine

  2012cites this paper
• Treatment of rheumatoid arthritis.

  2006cites this paper
• Treatment continuation rate in relation to efficacy and toxicity in long-term therapy with low-dose methotrexate, sulfasalazine, and bucillamine in 1,358 Japanese patients with rheumatoid arthritis.

  2006cites this paper
• Radiografía simple y artritis reumatoide. Lectura sistemática de la progresión radiológica y aplicaciones

  2005cites this paper
• The ability of disease modifying antirheumatic drugs to induce and maintain improvement in patients with rheumatoid arthritis. epidemiology of DMARDs treatment in Japan.

  2005cites this paper
• Comparison of augmented and non-augmented anterior cruciate ligament reconstruction combined with high tibial osteotomy

  2005cites this paper
• The relation between cartilage damage and osteophyte size in a murine model for osteoarthritis in the knee

  2005cites this paper
• Anterior cruciate ligament reconstruction combined with valgus tibial osteotomy (combined procedure)

  2005cites this paper
• Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review.

  2002cites this paper
• Sulfasalazine treatment for rheumatoid arthritis: a metaanalysis of 15 randomized trials.

  1999cites this paper
• Sulphasalazine in the treatment of rheumatoid arthritis.

  1997cites this paper
• The mechanisms of action of disease-modifying antirheumatic drugs: a review with emphasis on macrophage signal transduction and the induction of proinflammatory cytokines.

  1997cites this paper
• Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis.

  1995cites this paper
• DC-ART classification: review of relevant clinical studies.

  1994cites this paper
• DC-ART: preventing or significantly decreasing the rate of progression of structural joint damage.

  1994cites this paper
• Rheumatoid arthritis: a risk factor for sulphasalazine toxicity? A meta-analysis.

  1993cites this paper
• Penicillamine in Rheumatoid Arthritis

  1992cites this paper
• Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials.

  1992cites this paper
• The impact of endpoint measures in rheumatoid arthritis clinical trials.

  1992cites this paper
• The course and outcome of rheumatoid arthritis. Radiological measures of outcome.

  1992cites this paper
• 3 Radiological measures of outcome

  1992cites this paper
• Proposition: methotrexate should not be the first second-line agent to be used in rheumatoid arthritis if NSAIDs fail.

  1990cites this paper